Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema
Clinical trial NCT05324592 · COMPLETED
Trial details
- NCT number
- NCT05324592
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-26
- Primary completion
- 2021-09-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.